Fetal functional capabilities in response to maternal hypertonicity associated with altered central and peripheral angiotensinogen mRNA in rats.
Although a number of studies have shown neural, hormonal, and behavioral capabilities in the control of body fluid regulation under conditions of dehydration in adults, limited information is available on the development of fetal functional abilities in response to osmotic challenge in rats. This study was performed to investigate the influence of maternal hypertonicity on fetal osmoregulatory capabilities at late gestational time in rats. Maternal and fetal plasma osmolality and blood sodium levels were determined and compared at continuous time points from 0.5 to 9h following maternal injection of hypertonic NaCl. Subcutaneous administration of hypertonic saline evoked a rise in plasma osmolality and sodium concentrations in maternal rats and fetuses associated with an up-regulation in angiotensinogen gene mRNA in the fetal liver and down-regulation of the same gene in the fetal brain. The increased levels of fetal blood osmolality and sodium were less than that in their mothers, and the fetus took less time to balance the enhanced osmolality and sodium concentrations. The results suggest that there may exist additional mechanisms in utero at near-term in protecting fetuses from hypertonic challenge. In addition, molecular results in the present study provide new data on fetal angiotensinogen gene expressed differently in the liver and brain under the same condition of prenatal salt loading, indicating osmotic signals of intracellular dehydration related to an acute increase in angiotensinogen mRNA in the fetal liver, and subsequent decrease in angiotensinogen mRNA levels in the fetal brain.
Mao
Caiping
C
Perinatal Biology Center, Soochow University School of Medicine, Suzhou, China.
Lv
Juanxiu
J
Zhu
Hong
H
Zhou
Yun
Y
Chen
Rongzheng
R
Feng
Xin
X
Cui
Yugui
Y
Wang
Chen
C
Hui
Pengpeng
P
Xu
Feichao
F
Xu
Zhice
Z
D000808:Angiotensinogen / Q000235:genetics / Q000378:metabolism*; D000818:Animals; D005260:Female; D005333:Fetus / Q000187:drug effects / Q000378:metabolism; D006982:Hypertonic Solutions / Q000494:pharmacology*; D008431:Maternal-Fetal Exchange; D009994:Osmolar Concentration; D011247:Pregnancy; D012333:RNA, Messenger / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012964:Sodium / Q000097:blood; D012965:Sodium Chloride / Q000494:pharmacology; D013997:Time Factors
D006982:Hypertonic Solutions; D012333:RNA, Messenger; D000808:Angiotensinogen; D012965:Sodium Chloride; D012964:Sodium